The Company's MaSTherCell subsidiary is a global Contract Development and Manufacturing Organization (CDMO). Through MaSTherCell, Orgenesis is able to deliver optimized process industrialization capacities to cell therapy companies, and speed up the arrival of their therapies onto the market.

From technology selection to business modeling, GMP manufacturing, process development, quality management and assay development, MaSTherCell's teams are fully committed to helping our customers fulfill their objective of providing sustainable and affordable therapies to their patients.

The company operates in a validated and flexible facility located in the strategic center of Europe within the Walloon healthcare cluster, Biowin.

The key competitive advantages that MaSTherCell offers to both its customers and its partners are:

  • A custom-made approach, tailored to the specific requirements of our clients, and designed to ensure short lead times and competitive costs in getting products to the market.
  • An in-house expertise that is drawn from both academic and industry backgrounds. Our highly flexible staff structure combines the ideal mix between scientific and market-oriented disciplines.
  • A complete range of services - our advanced Project Management Program allows us to offer a centrally managed service that covers every step of the process 'from bench to market'.

MaSTherCell's customers include many of the world's leading pharmaceutical and biotech companies, as well as research institutions and hospitals involved in cutting edge cell therapy.